ALISON LEHNER focuses her practice on the life sciences and healthcare industries, representing companies at every life cycle stage. As a member of the Global Life Sciences team, Alison leverages a broad knowledge base to advise clients in a variety of complex transactions, including equity and debt financings, licensing, collaborations, co-promotions, M&A, structured finance arrangements, including royalty and revenue financing, and other strategic transactions. As part of this practice, Alison has advised clients on a broad range of issues related to cutting edge technology, such as digital heath and cell and gene therapies.
Alison represents private companies and publicly traded companies, and a significant portion of Alison’s practice involves working with entrepreneurs and inventors to develop companies that allow them to finance continued research and development outside of the academic environment. As part of this practice, Alison counsels inventors regarding formation, financing, licensing, and development transactions, as well as general corporate and commercial matters. Alison also regularly works with investors in the life sciences industry in connection with financing activities, as well as academic medical centers in licensing and strategic transactions, allowing her to bring experience to all sides of emerging company transactions. In connection with her emerging company experience, Alison has experience helping clinical-stage companies prepare for commercialization, including establishing global corporate activities, developing supply chains, and engaging with commercialization partners.